Preoperative coagulation studies to predict blood component usage in coronary artery bypass graft surgery

S. Josefy, R. Briones, Barbara Bryant

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Bleeding remains a serious complication of cardiac surgery. Studies indicate that preoperative fibrinogen concentration is an independent predictor of blood loss during coronary artery bypass graft (CABG) surgery. This study evaluates whether fibrinogen concentration is a better predictor of blood usage than the prothrombin time (PT) and activated partial thromboplastin time (aPTT) tests. Patients not taking clopidogrel bisulfate who underwent CABG surgery during a 3-month period at a 350-bed community hospital were included in this prospective study. The parameters evaluated included patient's age, preoperative coagulation test results (PT, international normalized ratio [INR], aPTT, fibrinogen), and number of blood components transfused. A probability value of less than 0.05 was deemed significant. Thirty-five patients were included in this study. Mean blood usage was 6 units. Patient's age approached significance as a predictor of blood usage, and fibrinogen levels trended toward significance more than the other coagulation parameters. In this study, the increased age of the patient and low plasma concentrations of fibrinogen were associated with increased blood usage. Although no indicators clearly demonstrated statistical significance, the vast difference in the probability values for patients' ages and fibrinogen levels indicated that there was a trend toward significance in blood usage for CABG patients. Further studies with larger patient populations are indicated.

Original languageEnglish (US)
Pages (from-to)151-153
Number of pages3
JournalImmunohematology
Volume27
Issue number4
StatePublished - 2011

Fingerprint

Coronary Artery Bypass
Fibrinogen
Transplants
Partial Thromboplastin Time
clopidogrel
Prothrombin Time
International Normalized Ratio
Community Hospital
Thoracic Surgery
Prospective Studies
Hemorrhage
Population

Keywords

  • Blood usage
  • Coagulation studies
  • Coronary artery bypass graft surgery

ASJC Scopus subject areas

  • Hematology
  • Immunology and Allergy

Cite this

Preoperative coagulation studies to predict blood component usage in coronary artery bypass graft surgery. / Josefy, S.; Briones, R.; Bryant, Barbara.

In: Immunohematology, Vol. 27, No. 4, 2011, p. 151-153.

Research output: Contribution to journalArticle

@article{ac15d7570d99414cabad255703e23e41,
title = "Preoperative coagulation studies to predict blood component usage in coronary artery bypass graft surgery",
abstract = "Bleeding remains a serious complication of cardiac surgery. Studies indicate that preoperative fibrinogen concentration is an independent predictor of blood loss during coronary artery bypass graft (CABG) surgery. This study evaluates whether fibrinogen concentration is a better predictor of blood usage than the prothrombin time (PT) and activated partial thromboplastin time (aPTT) tests. Patients not taking clopidogrel bisulfate who underwent CABG surgery during a 3-month period at a 350-bed community hospital were included in this prospective study. The parameters evaluated included patient's age, preoperative coagulation test results (PT, international normalized ratio [INR], aPTT, fibrinogen), and number of blood components transfused. A probability value of less than 0.05 was deemed significant. Thirty-five patients were included in this study. Mean blood usage was 6 units. Patient's age approached significance as a predictor of blood usage, and fibrinogen levels trended toward significance more than the other coagulation parameters. In this study, the increased age of the patient and low plasma concentrations of fibrinogen were associated with increased blood usage. Although no indicators clearly demonstrated statistical significance, the vast difference in the probability values for patients' ages and fibrinogen levels indicated that there was a trend toward significance in blood usage for CABG patients. Further studies with larger patient populations are indicated.",
keywords = "Blood usage, Coagulation studies, Coronary artery bypass graft surgery",
author = "S. Josefy and R. Briones and Barbara Bryant",
year = "2011",
language = "English (US)",
volume = "27",
pages = "151--153",
journal = "Immunohematology",
issn = "0894-203X",
publisher = "American Red Cross",
number = "4",

}

TY - JOUR

T1 - Preoperative coagulation studies to predict blood component usage in coronary artery bypass graft surgery

AU - Josefy, S.

AU - Briones, R.

AU - Bryant, Barbara

PY - 2011

Y1 - 2011

N2 - Bleeding remains a serious complication of cardiac surgery. Studies indicate that preoperative fibrinogen concentration is an independent predictor of blood loss during coronary artery bypass graft (CABG) surgery. This study evaluates whether fibrinogen concentration is a better predictor of blood usage than the prothrombin time (PT) and activated partial thromboplastin time (aPTT) tests. Patients not taking clopidogrel bisulfate who underwent CABG surgery during a 3-month period at a 350-bed community hospital were included in this prospective study. The parameters evaluated included patient's age, preoperative coagulation test results (PT, international normalized ratio [INR], aPTT, fibrinogen), and number of blood components transfused. A probability value of less than 0.05 was deemed significant. Thirty-five patients were included in this study. Mean blood usage was 6 units. Patient's age approached significance as a predictor of blood usage, and fibrinogen levels trended toward significance more than the other coagulation parameters. In this study, the increased age of the patient and low plasma concentrations of fibrinogen were associated with increased blood usage. Although no indicators clearly demonstrated statistical significance, the vast difference in the probability values for patients' ages and fibrinogen levels indicated that there was a trend toward significance in blood usage for CABG patients. Further studies with larger patient populations are indicated.

AB - Bleeding remains a serious complication of cardiac surgery. Studies indicate that preoperative fibrinogen concentration is an independent predictor of blood loss during coronary artery bypass graft (CABG) surgery. This study evaluates whether fibrinogen concentration is a better predictor of blood usage than the prothrombin time (PT) and activated partial thromboplastin time (aPTT) tests. Patients not taking clopidogrel bisulfate who underwent CABG surgery during a 3-month period at a 350-bed community hospital were included in this prospective study. The parameters evaluated included patient's age, preoperative coagulation test results (PT, international normalized ratio [INR], aPTT, fibrinogen), and number of blood components transfused. A probability value of less than 0.05 was deemed significant. Thirty-five patients were included in this study. Mean blood usage was 6 units. Patient's age approached significance as a predictor of blood usage, and fibrinogen levels trended toward significance more than the other coagulation parameters. In this study, the increased age of the patient and low plasma concentrations of fibrinogen were associated with increased blood usage. Although no indicators clearly demonstrated statistical significance, the vast difference in the probability values for patients' ages and fibrinogen levels indicated that there was a trend toward significance in blood usage for CABG patients. Further studies with larger patient populations are indicated.

KW - Blood usage

KW - Coagulation studies

KW - Coronary artery bypass graft surgery

UR - http://www.scopus.com/inward/record.url?scp=84864762816&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84864762816&partnerID=8YFLogxK

M3 - Article

VL - 27

SP - 151

EP - 153

JO - Immunohematology

JF - Immunohematology

SN - 0894-203X

IS - 4

ER -